Hvad er Y-tunnus-nummeret på Oy Citotest Ab?

Oy Citotest Ab er registreret hos PRH / YTJ under Y-tunnus 0181560-7.

Hvad er omsætningen for Oy Citotest Ab?

Oy Citotest Ab rapporterede en omsætning på 255,8 t. € i 2021.

Oy Citotest Abs registrerede adresse er Stationsvägen 1.

OYIn liquidation

Y-tunnus 0181560-7Stationsvägen 1, 68600 JakobstadDiagnostic imaging services and medical laboratory activities· NACE 8691Stiftet 1978 · 48 år gammel— ansatte

Nuværende ledelse

Name	Role	Member since
Current (4)
NJ Nina Johanna Östman-Tylli Deputy auditor	Deputy auditor	2014
RH Riitta Hannele Huhtala Liquidator	Liquidator	2026
KG Karl Göran Wiklund Audit	Audit	2014
ML Mårten Lars Johan Kjellman Audit	Audit	2014

Tidligere (5)


MH Monika Helena Backa Deputy Member	Deputy Member	2018 – 2020
CM Christine Maria Dahlbacka Deputy Member	Deputy Member	2022 – 2026
SO Sune Olav Mattias Junell

Bestyrelsestilsyn

Name	Role	Member since

Tidligere (13)


MH Monika Helena Backa Board of Directors	Board of Directors	2020 – 2021
TH Tina Helena Ademola Board of Directors	Board of Directors	2020 – 2022
NA Niklas Anders Österholm Board of Directors	Board of Directors	2018 – 2020
JA Jyrki Antero Sironen Board of Directors	Board of Directors	2018 – 2019
LK Lena Kristina Holmberg Board of Directors	Board of Directors	2018 – 2022
RH Riitta Hannele Huhtala Board of Directors	Board of Directors	2021 – 2022
HS Heli Susanna Peltokangas Board of Directors	Board of Directors	2022 – 2026
TB Tiina Birgitta Sjölund Chairperson	Chairperson	2018 – 2020
JE Jenni Eveliina Koski Board of Directors	Board of Directors	2022 – 2026
MH Mikael Henry Johannes Snellman Board of Directors	Board of Directors	2022 – 2026
JH Jan-Erik Höglund Board of Directors	Board of Directors	2022 – 2026
LM Leena Maria Kinaret Board of Directors	Board of Directors	2019 – 2020
MJ Mikael Jan Martin Häggman Board of Directors	Board of Directors	2021 – 2022

Pr. seneste årsrapport

No shareholder data available.

Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.